Job Opening: Machine Learning, Deep Tech Applications
SilcsBio's parent company, Early Charm, has a job opening to work with SilcsBio and other portfolio companies focused on Drug Design and Machine Vision. Immediate Job Opening Machine Learning Deep Tech Applications July 27, 2021 What we do: Early Charm creates, owns, and operates businesses that [...]
Job Opening: Full-Stack Developer, Deep Tech Applications
SilcsBio's parent company, Early Charm, has a job opening to work with SilcsBio and other portfolio companies focused on Drug Design and Machine Vision. Immediate Job Opening Full-Stack Developer Deep Tech Applications July 27, 2021 What we do: Early Charm creates, owns, and operates businesses that [...]
SilcsBio is Selected by the NIH to 2021 BIO Digital’s Innovation Zone, June 10-11 and 14-18
FOR IMMEDIATE RELEASE: SilcsBio is Selected by the NIH to 2021 BIO Digital’s Innovation Zone, June 10-11 and 14-18 SilcsBio’s Sunhwan Jo to attend BIO Digital with focus on SilcsBio's expertise in fragment-based drug design, MD simulations, and computational drug discovery June 8, 2021, Baltimore, MD – SilcsBio, [...]
AChE Inhibition: Profiling the Tox21 Chemical Collection
In vitro and molecular docking of environmental chemicals from the Tox21 Chemical Collection to probe AChE inhibition, a biomarker for possible drug safety/toxicity implications. Full text: https://doi.org/10.1289/EHP6993
